Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2016 |
| Outros Autores: | , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/28202 |
Resumo: | Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil. |
| id |
CRUZ_c66ac38b4ce773e5ea0d58a620376b0d |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/28202 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Borzacov, Lourdes Maria Pinheiro.Nicolete, Larissa Deadame de Figueiredo.Souza, Luan Felipo Botelho.Santos, Alcione Oliveira dos.Vieira, Deusilene Souza.Salcedo, Juan Miguel Villalobos.2018-08-16T21:18:01Z2018-08-16T21:18:01Z2016BORZACOV, L.M.P., et al. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. International Journal of Infectious Diseases, v. 46, p. 82-88, 2016.1201-9712https://www.arca.fiocruz.br/handle/icict/282021878-3511engElsevierTreatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavirinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFederal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil.Objectives: Hepatitis delta virus (HDV) is recognized as the most pathogenic and infectious among the hepatotropic viruses. Studies on the treatment of HDV have predominantly included European patients and carriers of genotype 1 (HDV-1) in their clinical protocols. For the Amazon region, data show that infected individuals have mainly Native American ancestry and that >90% of HDV carriers have the genotype 3 (HDV-3). Thus combined therapy clinical protocols do not adequately address the treatment of these patients. Methods: A prospective, non-randomized study was conducted in which 22 patients received 180 mg of pegylated interferon alpha 2a (PEG-IFN) plus entecavir at a dose of 0.5 mg for 48 weeks, with a subsequent 24-week follow-up. Throughout treatment, the patients were monitored for biochemical responses and the kinetics of hepatitis B virus (HBV) and HDV viral loads. Results: Of the 22 patients treated, 15 presented normal alanine aminotransferase values at the end of treatment (p = 0.002). At week 24 of treatment, 86.4% of the patients did not present detectable HDV- RNA; at week 48, the rate of negative patients increased to >95% and remained the same after 6 months. With regard to HBV, only two patients (9%) still presented detectable HBV genetic material at the end of treatment, suggesting the effectiveness of combined therapy in combating the two viruses. Conclusions: These findings support the use of this effective therapeutic protocol for HDV-3 in patients of non-European ethnicity and suggest a possible ‘easy to treat’ variant when compared to HDV-1.HDVGenotype 3TreatmentPEG-IFNEntecavirinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/28202/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALTreatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.pdfTreatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.pdfapplication/pdf640164https://www.arca.fiocruz.br/bitstream/icict/28202/2/Treatment%20of%20hepatitis%20delta%20virus%20genotype%203%20infection%20with%20peg-interferon%20and%20entecavir.pdfeb2dc45fe4928bedd19a2bf93c05444dMD52TEXTTreatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.pdf.txtTreatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.pdf.txtExtracted texttext/plain33053https://www.arca.fiocruz.br/bitstream/icict/28202/3/Treatment%20of%20hepatitis%20delta%20virus%20genotype%203%20infection%20with%20peg-interferon%20and%20entecavir.pdf.txt9349d125478fe7852ca6d960a7976aebMD53icict/282022018-08-17 02:00:46.337oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-08-17T05:00:46Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| title |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| spellingShingle |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir Borzacov, Lourdes Maria Pinheiro. HDV Genotype 3 Treatment PEG-IFN Entecavir |
| title_short |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| title_full |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| title_fullStr |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| title_full_unstemmed |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| title_sort |
Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir |
| author |
Borzacov, Lourdes Maria Pinheiro. |
| author_facet |
Borzacov, Lourdes Maria Pinheiro. Nicolete, Larissa Deadame de Figueiredo. Souza, Luan Felipo Botelho. Santos, Alcione Oliveira dos. Vieira, Deusilene Souza. Salcedo, Juan Miguel Villalobos. |
| author_role |
author |
| author2 |
Nicolete, Larissa Deadame de Figueiredo. Souza, Luan Felipo Botelho. Santos, Alcione Oliveira dos. Vieira, Deusilene Souza. Salcedo, Juan Miguel Villalobos. |
| author2_role |
author author author author author |
| dc.contributor.author.fl_str_mv |
Borzacov, Lourdes Maria Pinheiro. Nicolete, Larissa Deadame de Figueiredo. Souza, Luan Felipo Botelho. Santos, Alcione Oliveira dos. Vieira, Deusilene Souza. Salcedo, Juan Miguel Villalobos. |
| dc.subject.en.pt_BR.fl_str_mv |
HDV Genotype 3 Treatment PEG-IFN Entecavir |
| topic |
HDV Genotype 3 Treatment PEG-IFN Entecavir |
| description |
Federal University of Rondônia. Research Center for Tropical Medicine of Rondônia. Porto Velho, RO, Brasil. |
| publishDate |
2016 |
| dc.date.issued.fl_str_mv |
2016 |
| dc.date.accessioned.fl_str_mv |
2018-08-16T21:18:01Z |
| dc.date.available.fl_str_mv |
2018-08-16T21:18:01Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
BORZACOV, L.M.P., et al. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. International Journal of Infectious Diseases, v. 46, p. 82-88, 2016. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/28202 |
| dc.identifier.issn.pt_BR.fl_str_mv |
1201-9712 |
| dc.identifier.eissn.none.fl_str_mv |
1878-3511 |
| identifier_str_mv |
BORZACOV, L.M.P., et al. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. International Journal of Infectious Diseases, v. 46, p. 82-88, 2016. 1201-9712 1878-3511 |
| url |
https://www.arca.fiocruz.br/handle/icict/28202 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/28202/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/28202/2/Treatment%20of%20hepatitis%20delta%20virus%20genotype%203%20infection%20with%20peg-interferon%20and%20entecavir.pdf https://www.arca.fiocruz.br/bitstream/icict/28202/3/Treatment%20of%20hepatitis%20delta%20virus%20genotype%203%20infection%20with%20peg-interferon%20and%20entecavir.pdf.txt |
| bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 eb2dc45fe4928bedd19a2bf93c05444d 9349d125478fe7852ca6d960a7976aeb |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813008965588484096 |